Work

Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases (P1-5.001)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000201746

Authors: Kelly Gwathmey, Catherine Broome, Matthias Goebeler, Hiroyuki Murai, Zsuzsanna Bata-Csorgo, Adrian Newland, Peter Ulrichts, Rene Kerstens, Jeffrey Guptill, Sofiane Agha, Ming Jiang, James Howard

Institutions: Virginia Commonwealth University, Georgetown University, Universitätsklinikum Würzburg, International University of Health and Welfare, University of Szeged, Queen Mary University of London, Argenx (Belgium), University of North Carolina at Chapel Hill

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367305156

FWCI: 0.165

Cites:

Cited by: 1

Related to: 10